A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.
NCT00139672
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
330
Enrollment
INDUSTRY
Sponsor class
Conditions
Irritable Bowel Syndrome
Interventions
DRUG:
PD-217,014
Sponsor
Pfizer